RCF Appoints Dr. Krishna Kant Pathak as Government Nominee Director
Rashtriya Chemicals and Fertilizers Limited (RCF) has appointed Dr. Krishna Kant Pathak as a Government Nominee Director. The appointment is effective April 21, 2026, for a term of three years or until further orders. Dr. Pathak is an IAS officer and currently serves as Joint Secretary in the Department of Fertilizers.
The appointment of a Government Nominee Director can influence strategic decisions and governance, thus having a medium-term impact on the company's operations and direction.
The appointment of a director is a routine corporate governance event and does not inherently carry a positive or negative financial implication for the company.
Rashtriya Chemicals and Fertilizers Limited (RCF) announced the appointment of Dr. Krishna Kant Pathak (DIN: 08328847) as a Government Nominee Director on its Board. The appointment was approved by the Board of Directors through a Circular Resolution passed on April 21, 2026.
Dr. Pathak's tenure will be for a period of three years, effective immediately, or until his superannuation, or on a co-terminus basis with his posting in the Department of Fertilizers, or until further orders, whichever is the earliest. This appointment is in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dr. Krishna Kant Pathak is an Indian Administrative Service (IAS) Officer from the 2001 batch, Rajasthan cadre, holding an M.A. and Ph.D. from Allahabad University. He currently serves as the Joint Secretary in the Department of Fertilizers, Ministry of Chemicals and Fertilizers. His extensive experience spans various senior roles in both the Rajasthan and Central governments, including positions in finance, rural development, and public administration. He has also served as District Collector & Magistrate and been associated with the Chief Minister's Office in Rajasthan.
What to do with a filing like this
Rashtriya Chemicals and Fertilizers Limited filed this with the NSE as a statutory disclosure, categorised under board changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rashtriya Chemicals and Fertilizers Limited. Read the original for the full detail.